Sign in
IN2 ASSESSEMENT OF THE ADDITIONAL COST OF DROTRECOGIN ALFA (ACTIVATED) RELATIVE TO STANDARD CARE IN THE TREATMENT OF SEVERE SEPSIS IN A MULTICENTIC OBSERVATIONAL STUDY IN FRANCE
Journal article   Open access  Peer reviewed

IN2 ASSESSEMENT OF THE ADDITIONAL COST OF DROTRECOGIN ALFA (ACTIVATED) RELATIVE TO STANDARD CARE IN THE TREATMENT OF SEVERE SEPSIS IN A MULTICENTIC OBSERVATIONAL STUDY IN FRANCE

S Payet, L Riou França, K Le Lay, J F Dhainaut, B Vallet and R Launois
Value in health, Vol.8(6), pp.A20-A20
01/11/2005
url
https://doi.org/10.1016/S1098-3015(10)67200-2View
Published (Version of record) Open

Metrics

1 Record Views

Details